SIRT5 Human

Sirtuin-5 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction

Sirtuin 5 (SIRT5) is a NAD⁺-dependent mitochondrial deacylase belonging to the sirtuin family, class III histone deacetylases. It regulates diverse metabolic pathways, including glycolysis, fatty acid oxidation, and the tricarboxylic acid (TCA) cycle, through post-translational modifications such as desuccinylation, demalonylation, and deglutarylation . Emerging research highlights its dual roles in both physiological homeostasis and pathological conditions, including cancer, neurodegeneration, and cardiovascular diseases .

Recombinant Production

Recombinant human SIRT5 (32.5 kDa) is produced in E. coli with an N-terminal His-tag . Key applications include enzymatic assays and structural studies.

Enzymatic Activities

SIRT5 exhibits weak deacetylase activity but robust deacylase functions:

ActivityPrimary SubstratesBiological Impact
DesuccinylationGAPDH, PDH, VLCADPromotes glycolysis, fatty acid oxidation
DemalonylationGAPDH, CPS1Enhances urea cycle, redox balance
DeglutarylationG6PD, IDH2Regulates NADPH production, ROS detoxification

Key Mechanistic Insights:

  • SIRT5’s deacetylase activity is uniquely resistant to nicotinamide inhibition (IC₅₀ = 1.6 mM vs. 43 µM for SIRT3) .

  • Its desuccinylase activity is highly sensitive to nicotinamide, mediated by Arg105 in the catalytic pocket .

Glycolysis and TCA Cycle

  • GAPDH Demalonylation: Enhances glycolytic flux by activating glyceraldehyde-3-phosphate dehydrogenase .

  • PDH Regulation: Desuccinylates pyruvate dehydrogenase complex (PDC), suppressing pyruvate-to-acetyl-CoA conversion under stress .

Fatty Acid Oxidation (FAO)

  • VLCAD Desuccinylation: Stabilizes mitochondrial membrane localization of very-long-chain acyl-CoA dehydrogenase, boosting FAO .

  • ECHA Activation: Desuccinylates enoyl-CoA hydratase α-subunit, enhancing ATP production during fasting .

Redox Homeostasis

  • IDH2 Deglutarylation: Activates isocitrate dehydrogenase 2, supporting NADPH synthesis and antioxidant defense .

Implications in Cancer

SIRT5 exhibits context-dependent roles in tumorigenesis:

Cancer TypeRoleMechanism
Breast CancerTumor promoterStabilizes mitochondrial glutaminase (GLS), fueling tumor growth
Colorectal CancerTumor promoterActivates transketolase (TKT) to sustain nucleotide synthesis
Hepatocellular CarcinomaTumor promoterInhibits cytochrome c-mediated apoptosis
GliomasTumor suppressorRegulates synaptic remodeling and immune response

Clinical Correlations:

  • High SIRT5 expression correlates with poor prognosis in breast cancer (HR = 1.67) .

  • SIRT5 copy-number gains occur in 25–60% of ovarian, melanoma, and breast tumors .

Cardiovascular Disease

  • Myocardial Injury: SIRT5 deficiency reduces ATP synthesis and exacerbates oxidative stress during ischemia .

  • Cardiac Hypertrophy: Regulates succinate dehydrogenase (SDH-a) to mitigate ROS generation .

Neurodegeneration

  • Protective Role: Desuccinylates SOD1 and IDH2, reducing oxidative damage in neurons .

Inhibitors and Activators

CompoundTarget ActivityEffect
NRD-167SIRT5 inhibitorBlocks desuccinylation, reduces tumor growth
MC3138SIRT5 activatorEnhances G6PD activity, improves redox balance

Challenges

  • Developing isoform-specific modulators remains difficult due to structural similarities among sirtuins .

  • Context-dependent roles complicate therapeutic targeting (e.g., dual tumor-promoting/suppressing effects) .

Product Specs

Introduction
SIRT5 is a member of the Sirtuin family of proteins, which are homologs to the yeast Sir2 protein. Sirtuin family members share a conserved sirtuin core domain and are classified into four classes. SIRT5 belongs to class III of the sirtuin family. While the exact functions of human sirtuins are not fully understood, yeast sirtuin proteins are known to regulate epigenetic gene silencing and suppress recombination of rDNA. Studies suggest that human sirtuins may act as intracellular regulatory proteins with mono-ADP-ribosyltransferase activity.
Description
Recombinant human SIRT5 protein, expressed in E. coli, is a single, non-glycosylated polypeptide chain encompassing the topological domain (amino acids 34-310). It has a molecular mass of 32.5 kDa. The protein includes a 23 amino acid His-tag fused to the N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
The product is a clear, sterile-filtered solution.
Formulation
SIRT5 protein is provided at a concentration of 0.5 mg/ml in a solution containing 20 mM Tris-HCl buffer (pH 8.0), 0.15 M NaCl, 1 mM DTT, and 30% glycerol.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to freeze the product at -20°C. To ensure long-term stability, consider adding a carrier protein (0.1% HSA or BSA) before freezing. Avoid repeated freeze-thaw cycles.
Purity
The purity of the SIRT5 protein is greater than 90%, as determined by SDS-PAGE analysis.
Synonyms
Sirtuin 5, NAD-Dependent Lysine Demalonylase And Desuccinylase Sirtuin-5,Mitochondria, NAD-Dependent Protein Deacylase Sirtuin-5 Mitochondrial, Silent Mating Type Information Regulation 2 (S.Cerevisiae) Homolog 5, NAD-Dependent Deacetylase Sirtuin-5, Regulatory Protein SIR2 Homolog 5, SIR2-Like Protein 5, SIR2L5, Sirtuin Type 5, Sir2-Like 5, EC 3.5.1.-.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSARPSSSM ADFRKFFAKA KHIVIISGAG VSAESGVPTF RGAGGYWRKW QAQDLATPLA FAHNPSRVWE FYHYRREVMG SKEPNAGHRA IAECETRLGK QGRRVVVITQ NIDELHRKAG TKNLLEIHGS LFKTRCTSCG VVAENYKSPI CPALSGKGAP EPGTQDASIP VEKLPRCEEA GCGGLLRPHV VWFGENLDPA ILEEVDRELA HCDLCLVVGT SSVVYPAAMF APQVAARGVP VAEFNTETTP ATNRFRFHFQ GPCGTTLPEA LACHENETVS

Q&A

Basic Research Questions

  • What is the biochemical function of human SIRT5?

Human SIRT5 functions primarily as a NAD+-dependent deacylase that removes succinyl, malonyl, and glutaryl groups from lysine residues on various proteins. Unlike other sirtuins that predominantly function as deacetylases, SIRT5 exhibits specialized activity toward these negatively charged acyl modifications .

Methodologically, SIRT5 activity can be assessed through:

  • Fluorescence-based deacylase activity assays

  • Mass spectrometry detection of substrate modifications

  • Targeted metabolic enzyme activity measurements

When studying SIRT5's enzymatic function, researchers should incorporate both in vitro biochemical assays and cellular systems to comprehensively characterize its activity profile.

  • How is SIRT5 distributed across human tissues and subcellular compartments?

Human SIRT5 exists in four isoforms with distinct subcellular localizations:

  • SIRT5 iso1-3: Predominantly mitochondrial

  • SIRT5 iso4: Primarily cytoplasmic

While cDNAs of all SIRT5 isoforms have been detected across multiple tissues, at the protein level, SIRT5 iso1 is most abundant, with iso2-4 rarely observed in human cell lines .

For accurate subcellular localization studies, researchers should employ:

  • Immunofluorescence microscopy with isoform-specific antibodies

  • Subcellular fractionation coupled with Western blotting

  • Expression of tagged isoforms with subsequent microscopy

  • What methodological approaches best assess SIRT5 enzymatic activity?

Quantifying SIRT5 activity requires careful consideration of assay conditions:

MethodAdvantagesLimitationsOptimal Applications
Fluorescence-based assaysHigh throughput, sensitiveMay not reflect physiological substratesInitial screening, kinetic studies
Mass spectrometryDirect substrate modification detectionRequires specialized equipmentComprehensive substrate identification
Western blotting with modification-specific antibodiesAccessible, target-specificLimited quantificationValidation of specific substrates
Targeted metabolic enzyme assaysFunctional relevanceIndirect measurementPhysiological impact assessment

For robust enzymatic characterization, researchers should optimize for:

  • NAD+ concentration (typically 1-5 mM)

  • pH (optimal range 7.5-8.5)

  • Substrate specificity (preferably physiological targets)

  • Appropriate controls (inactive mutants, competitive inhibitors)

Advanced Research Questions

  • How do human SIRT5 variants affect enzyme structure and function?

Several clinically relevant SIRT5 variants have been identified with altered functional properties:

VariantStructural ImpactFunctional EffectDisease Association
P114TSubtle structural deviationReduced stability and activityPotential mitochondrial disease
L128VNot fully characterizedReduced stability and activityPotential mitochondrial disease
F101LAffects catalytic domainAltered MaK regulationOsteoarthritis

The crystal structure of the P114T enzyme shows only subtle deviations from wild-type, yet results in significant functional impairment . When investigating novel variants, researchers should employ:

  • Protein crystallography to determine structural alterations

  • Thermal stability assays to assess protein stability

  • Enzymatic activity measurements comparing wild-type and variant proteins

  • Cellular studies examining protein half-life and expression levels

  • Metabolic profiling to identify downstream consequences

  • What is the relationship between SIRT5 and metabolic dysregulation in disease models?

SIRT5 deficiency manifests differently depending on genetic background, sex, and environmental factors:

In animal models, SIRT5 knockout mice exhibit:

  • Greater glucose intolerance than wild-type counterparts regardless of sex

  • Sex-specific differences in body composition responses to high-fat diet

  • Enhanced cartilage degradation, particularly exacerbated by high-fat diet in males

To investigate SIRT5's metabolic functions, researchers should consider:

  • Sex-stratified analyses due to observed sexual dimorphism

  • Dietary interventions (particularly high-fat diet) to reveal phenotypes

  • Combined measurement of systemic metabolism and tissue-specific effects

  • Longitudinal studies to capture age-dependent phenotypes

  • How does SIRT5 regulate the mitochondrial proteome?

SIRT5 significantly impacts the mitochondrial lysine succinylome, with quantitative proteomics revealing:

  • 32% of succinylated lysine sites increase more than twofold in SIRT5 knockout models

  • SIRT5 targets exhibit specific sequence preferences, with enrichment of serine or threonine at multiple positions (-8, -6, -5, -4, -1, +1, +3)

  • Approximately 29% of SIRT5 target sites are 100% conserved across seven vertebrate species

For comprehensive mitochondrial proteome analysis, researchers should implement:

  • Label-free quantitative proteomics comparing wild-type and SIRT5-deficient samples

  • Enrichment strategies for specific acyl modifications

  • Bioinformatic analyses to identify sequence motifs and pathway enrichment

  • Functional validation of key targets through directed enzymatic assays

  • What experimental approaches best capture SIRT5's role in cartilage metabolism and osteoarthritis?

Recent findings link SIRT5 to osteoarthritis development through regulation of chondrocyte metabolism:

  • Human OA-associated SIRT5^F101L mutation affects the catalytic domain and alters MaK levels

  • SIRT5-deficient mice exhibit early signs of proteoglycan loss and enhanced cartilage damage

  • High-fat diet exacerbates cartilage degeneration in SIRT5-deficient mice, particularly in males

Effective experimental approaches include:

  • Human genetic studies to identify disease-associated variants

  • Primary chondrocyte cultures from normal and osteoarthritic tissues

  • Tissue-specific conditional knockout models to distinguish local versus systemic effects

  • Proteomics to identify chondrocyte-specific SIRT5 substrates

  • Histological assessment with validated scoring systems (OARSI, Mankin scores)

  • How do genetic and environmental factors interact with SIRT5 function?

SIRT5 function is influenced by both genetic and environmental variables:

  • Tissue-specific conditional knockout models show different phenotypes than systemic knockouts

  • High-fat diet reveals metabolic phenotypes not apparent under standard conditions

  • Sex-specific differences in SIRT5-related phenotypes suggest hormonal influences

To investigate these interactions, researchers should design studies with:

  • Multiple genetic models (global vs. tissue-specific knockouts)

  • Environmental interventions (dietary modifications, stress conditions)

  • Sex-stratified analyses to capture hormonal influences

  • Age-dependent phenotyping to identify temporal effects

  • Multi-omics approaches to capture system-wide responses

  • What are the distinguishing characteristics of SIRT5 compared to other sirtuins?

SIRT5's unique properties among the sirtuin family include:

FeatureSIRT5Other Sirtuins
Primary enzymatic activityDesuccinylase, demalonylase, deglutarylasePrimarily deacetylases (SIRT1,2,3)
Subcellular localizationMitochondrial and cytosolic isoformsVarious (nuclear, cytosolic, mitochondrial)
Target sequence preferenceEnrichment of serine/threonine at specific positionsVaries by sirtuin
Metabolic pathway regulationCarbon metabolism, glycolysisVaries (e.g., SIRT3: fatty acid oxidation)

Unlike SIRT3 deficiency, which causes severe consequences through protein hyperacetylation, SIRT5 deficiency produces more subtle phenotypes that may be revealed under stress conditions or with aging .

  • How conserved are SIRT5 targets across species?

Evolutionary analysis reveals high conservation of SIRT5 substrate sites:

  • 72% of mouse SIRT5 target sites are conserved in humans

  • 67% are conserved in zebrafish

  • About 29% of SIRT5 target sites are 100% conserved across seven vertebrate species

This remarkable conservation suggests fundamental metabolic functions under evolutionary pressure. Researchers investigating conserved targets should:

  • Perform comparative genomics across species

  • Validate conservation of both sequence and modification

  • Test cross-species activity with recombinant enzymes

  • Use conservation as a filter to prioritize functionally critical targets

  • What methodological considerations are important when developing mouse models of human SIRT5 variants?

When modeling human SIRT5 variants in mice, researchers should consider:

  • CRISPR-Cas9 gene editing to precisely recapitulate human mutations

  • Validation of protein expression, stability, and activity

  • Comprehensive phenotyping across multiple physiological systems

  • Exposing models to relevant environmental stressors

  • Comparing tissue-specific versus global expression of variants

The P114T mouse model recapitulates reduced SIRT5 levels and activity observed in humans but does not display overt metabolic abnormalities or neuropathology under standard conditions , highlighting the importance of appropriate stressors to reveal phenotypes.

  • How does SIRT5 contribute to redox homeostasis?

SIRT5 significantly impacts cellular redox balance through:

  • Regulation of enzymes involved in glutathione metabolism

  • Modification of proteins in the electron transport chain

  • Control of reactive oxygen species-detoxifying enzymes

Loss-of-function SIRT5 variants lead to significant disruption of redox homeostasis . For comprehensive assessment of SIRT5's role in redox regulation, researchers should measure:

  • Glutathione levels (reduced and oxidized)

  • Protein carbonylation as marker of oxidative damage

  • Mitochondrial ROS production

  • Activity of key antioxidant enzymes

  • NAD+/NADH ratios as indicators of redox state

  • What analytical challenges exist in studying the SIRT5 interactome?

Comprehensive analysis of SIRT5 interactions presents several technical challenges:

ChallengeMethodological Solution
Low abundance of some SIRT5 isoformsTargeted enrichment strategies, overexpression systems
Transient interactionsCrosslinking approaches, proximity labeling
Multiple modification typesPan-specific and modification-specific enrichment
Compartment-specific interactionsFractionation before analysis, in situ proximity labeling
Distinguishing direct from indirect targetsIn vitro validation with recombinant proteins

Researchers should implement multiple complementary approaches and appropriate controls to comprehensively map the SIRT5 interactome across cellular compartments.

Product Science Overview

Introduction

Sirtuin-5 (SIRT5) is a member of the sirtuin family of proteins, which are homologs to the yeast Sir2 protein. These proteins are characterized by a sirtuin core domain and belong to the class III histone deacetylases (HDACs), which are dependent on nicotinamide adenine dinucleotide (NAD+) as a co-factor for their enzymatic activities .

Gene and Protein Structure

The SIRT5 gene is located on human chromosome 6p23 and consists of eight exons. The gene encodes two isoforms of the protein, one with 310 amino acids and another with 299 amino acids . The recombinant form of SIRT5 is typically expressed in Escherichia coli and has a molecular weight of approximately 59.8 kDa .

Enzymatic Activities

SIRT5 exhibits multiple enzymatic activities, including deacetylase, desuccinylase, demalonylase, and deglutarylase activities. These activities enable SIRT5 to remove acetyl, succinyl, malonyl, and glutaryl groups from lysine residues on proteins . This versatility in substrate specificity allows SIRT5 to play a crucial role in various cellular processes.

Biological Functions

SIRT5 is primarily localized to the mitochondria, where it is involved in regulating several metabolic pathways. One of its key functions is the regulation of carbamoyl phosphate synthetase 1 (CPS1), an essential enzyme in the urea cycle. SIRT5 deacetylates CPS1, thereby stimulating its enzymatic activity and facilitating the detoxification of ammonia in the liver .

Additionally, SIRT5 has been shown to interact with and deacetylate cytochrome c, a component of the electron transport chain, suggesting a role in energy metabolism . Large-scale profiling studies have identified over 700 protein substrates for SIRT5, indicating its widespread influence on mitochondrial and cellular functions .

Clinical Relevance

SIRT5 is overexpressed in non-small cell lung cancer (NSCLC) and may contribute to cancer growth . Its role in regulating metabolic pathways and maintaining cellular homeostasis makes it a potential target for therapeutic interventions in various diseases, including cancer and metabolic disorders.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.